Trials / Completed
CompletedNCT00933699
Dermacyd PH_DESILSTY_FL (Lactic Acid) - Acceptability - Stay on Floral.
Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynaecological Follow up - Dermacyd PH_DESILSTY_FL (Lactic Acid).
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Primary Objective: To prove the safety of the gynaecological formulation in normal conditions of use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LACTIC ACID(ND) | Treatment duration: 21 consecutive days |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2009-07-07
- Last updated
- 2010-09-14
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00933699. Inclusion in this directory is not an endorsement.